SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-22-023843
Filing Date
2022-02-15
Accepted
2022-02-15 16:54:36
Documents
13
Period of Report
2022-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm226828d1_8k.htm   iXBRL 8-K/A 59465
2 EXHIBIT 2.1 tm226828d1_ex2-1.htm EX-2.1 710468
  Complete submission text file 0001104659-22-023843.txt   1117947

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bdsi-20220213.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsi-20220213_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsi-20220213_pre.xml EX-101.PRE 22587
7 EXTRACTED XBRL INSTANCE DOCUMENT tm226828d1_8k_htm.xml XML 4050
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-31361 | Film No.: 22639923
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences